Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design

Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design

Abstract Background The symptom severity of a substantial group of schizophrenia patients (30–40%) does not improve through pharmacotherapy with antipsychotic medication, indicating a clear need for new treatment options to improve schizophrenia outcome. Meta-analyses, genetic studies, randomized co...

Full description

Bibliographic Details
Main Authors: Lyliana G. Nasib, Iris E. Sommer, Inge Winter - van Rossum, Jacqueline de Vries, Shiral S. Gangadin, Priscilla P. Oomen, Gurmeet Judge, Renske E. Blom, Jurjen J. Luykx, Nico J. M. van Beveren, Natalie D. Veen, Rune A. Kroken, Erik L. Johnsen
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Neuro-inflammation
Psychotic disorders
Prednisolone
Treatment
MRI
Online Access:http://link.springer.com/article/10.1186/s13063-020-04365-4

Internet

http://link.springer.com/article/10.1186/s13063-020-04365-4

Similar Items